Mayo study: Strong link found between researchers' views on diabetes drug and financial conflicts of interest

Posted on March 23rd, 2010 by

Almost all — some 94 percent — of the researchers who published favorable medical journal studies and commentaries on the controversial diabetes drug rosiglitazone had financial ties with pharmaceutical companies that manufacture it or similar drugs, a Mayo Clinic study has found…

 

“One-fourth of the folks who were having an opinion on this debate were not disclosing that they had a financial relationship,” said Victor Montori, MD, a Mayo Clinic endocrinologist and one of the authors of the study, in a telephone interview last week.

 

MinnPost, by Susan Perry, 3/22/2010

Tags: Conflict of interest, Conflict of interest, Dr. Victor Montori

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy